The global market for Long-acting and Short-acting Oral Contraceptives was estimated to be worth US$ 611 million in 2023 and is forecast to a readjusted size of US$ 765.5 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030

Long-acting and Short-acting Oral Contraceptives - Market

Oral contraceptives (birth control pills) are hormone-containing medications that are taken by mouth to prevent pregnancy. They prevent pregnancy by inhibiting ovulation and also by preventing sperm from penetrating through the cervix.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting and Short-acting Oral Contraceptives, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Long-acting and Short-acting Oral Contraceptives by region & country, by Type, and by Application.

The Long-acting and Short-acting Oral Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting and Short-acting Oral Contraceptives.

Market Segmentation

Scope of Long-acting and Short-acting Oral Contraceptives - Market Report

Report Metric	Details
Report Name	Long-acting and Short-acting Oral Contraceptives - Market
Forecasted market size in 2030	US$ 765.5 million
CAGR	3.3%
Forecasted years	2024 - 2030
Segment by Type:	Combined Contraceptive Pill Low Dose Oral Contraceptive
Segment by Application	Hospital Pharmacies Private Clinics Retail Pharmacies E-Commerce
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Paladin Labs, Theramex (Teva), Pfizer, Apotex, HRA Pharma, HLL Life Care, Mankind, Piramal, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Long-acting and Short-acting Oral Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Long-acting and Short-acting Oral Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Long-acting and Short-acting Oral Contraceptives in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Long-acting and Short-acting Oral Contraceptives - Market size in 2030?

Ans: The Long-acting and Short-acting Oral Contraceptives - Market size in 2030 will be US$ 765.5 million.

Who are the main players in the Long-acting and Short-acting Oral Contraceptives - Market report?

Ans: The main players in the Long-acting and Short-acting Oral Contraceptives - Market are Bayer, Paladin Labs, Theramex (Teva), Pfizer, Apotex, HRA Pharma, HLL Life Care, Mankind, Piramal, Allergan

What are the Application segmentation covered in the Long-acting and Short-acting Oral Contraceptives - Market report?

Ans: The Applications covered in the Long-acting and Short-acting Oral Contraceptives - Market report are Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce

What are the Type segmentation covered in the Long-acting and Short-acting Oral Contraceptives - Market report?

Ans: The Types covered in the Long-acting and Short-acting Oral Contraceptives - Market report are Combined Contraceptive Pill, Low Dose Oral Contraceptive

1 Market Overview

1.1 Long-acting and Short-acting Oral Contraceptives Product Introduction

1.2 Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast

1.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales Value (2019-2030)

1.2.2 Global Long-acting and Short-acting Oral Contraceptives Sales Volume (2019-2030)

1.2.3 Global Long-acting and Short-acting Oral Contraceptives Sales Price (2019-2030)

1.3 Long-acting and Short-acting Oral Contraceptives Market Trends & Drivers

1.3.1 Long-acting and Short-acting Oral Contraceptives Industry Trends

1.3.2 Long-acting and Short-acting Oral Contraceptives Market Drivers & Opportunity

1.3.3 Long-acting and Short-acting Oral Contraceptives Market Challenges

1.3.4 Long-acting and Short-acting Oral Contraceptives Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Long-acting and Short-acting Oral Contraceptives Players Revenue Ranking (2023)

2.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Company (2019-2024)

2.3 Global Long-acting and Short-acting Oral Contraceptives Players Sales Volume Ranking (2023)

2.4 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Company Players (2019-2024)

2.5 Global Long-acting and Short-acting Oral Contraceptives Average Price by Company (2019-2024)

2.6 Key Manufacturers Long-acting and Short-acting Oral Contraceptives Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Long-acting and Short-acting Oral Contraceptives Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Long-acting and Short-acting Oral Contraceptives

2.9 Long-acting and Short-acting Oral Contraceptives Market Competitive Analysis

2.9.1 Long-acting and Short-acting Oral Contraceptives Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Long-acting and Short-acting Oral Contraceptives Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting and Short-acting Oral Contraceptives as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Combined Contraceptive Pill

3.1.2 Low Dose Oral Contraceptive

3.2 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Type

3.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Long-acting and Short-acting Oral Contraceptives Sales Value, by Type (2019-2030)

3.2.3 Global Long-acting and Short-acting Oral Contraceptives Sales Value, by Type (%) (2019-2030)

3.3 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Type

3.3.1 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Long-acting and Short-acting Oral Contraceptives Sales Volume, by Type (2019-2030)

3.3.3 Global Long-acting and Short-acting Oral Contraceptives Sales Volume, by Type (%) (2019-2030)

3.4 Global Long-acting and Short-acting Oral Contraceptives Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacies

4.1.2 Private Clinics

4.1.3 Retail Pharmacies

4.1.4 E-Commerce

4.2 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Application

4.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Long-acting and Short-acting Oral Contraceptives Sales Value, by Application (2019-2030)

4.2.3 Global Long-acting and Short-acting Oral Contraceptives Sales Value, by Application (%) (2019-2030)

4.3 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Application

4.3.1 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Long-acting and Short-acting Oral Contraceptives Sales Volume, by Application (2019-2030)

4.3.3 Global Long-acting and Short-acting Oral Contraceptives Sales Volume, by Application (%) (2019-2030)

4.4 Global Long-acting and Short-acting Oral Contraceptives Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region

5.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region (2019-2024)

5.1.3 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region (2025-2030)

5.1.4 Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region (%), (2019-2030)

5.2 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region

5.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (2019-2024)

5.2.3 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (2025-2030)

5.2.4 Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (%), (2019-2030)

5.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

5.4.2 North America Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

5.5.2 Europe Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

5.6.2 Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

5.7.2 South America Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

5.8.2 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Value

6.2.1 Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.2.2 Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.3.2 United States Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Long-acting and Short-acting Oral Contraceptives Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.4.2 Europe Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Long-acting and Short-acting Oral Contraceptives Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.5.2 China Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

6.5.3 China Long-acting and Short-acting Oral Contraceptives Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.6.2 Japan Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Long-acting and Short-acting Oral Contraceptives Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.7.2 South Korea Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Long-acting and Short-acting Oral Contraceptives Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.8.2 Southeast Asia Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Long-acting and Short-acting Oral Contraceptives Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Long-acting and Short-acting Oral Contraceptives Sales Value, 2019-2030

6.9.2 India Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

6.9.3 India Long-acting and Short-acting Oral Contraceptives Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bayer

7.1.1 Bayer Company Information

7.1.2 Bayer Introduction and Business Overview

7.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bayer Long-acting and Short-acting Oral Contraceptives Product Offerings

7.1.5 Bayer Recent Development

7.2 Paladin Labs

7.2.1 Paladin Labs Company Information

7.2.2 Paladin Labs Introduction and Business Overview

7.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Offerings

7.2.5 Paladin Labs Recent Development

7.3 Theramex (Teva)

7.3.1 Theramex (Teva) Company Information

7.3.2 Theramex (Teva) Introduction and Business Overview

7.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Offerings

7.3.5 Theramex (Teva) Recent Development

7.4 Pfizer

7.4.1 Pfizer Company Information

7.4.2 Pfizer Introduction and Business Overview

7.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Long-acting and Short-acting Oral Contraceptives Product Offerings

7.4.5 Pfizer Recent Development

7.5 Apotex

7.5.1 Apotex Company Information

7.5.2 Apotex Introduction and Business Overview

7.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Apotex Long-acting and Short-acting Oral Contraceptives Product Offerings

7.5.5 Apotex Recent Development

7.6 HRA Pharma

7.6.1 HRA Pharma Company Information

7.6.2 HRA Pharma Introduction and Business Overview

7.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.6.4 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Offerings

7.6.5 HRA Pharma Recent Development

7.7 HLL Life Care

7.7.1 HLL Life Care Company Information

7.7.2 HLL Life Care Introduction and Business Overview

7.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.7.4 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Offerings

7.7.5 HLL Life Care Recent Development

7.8 Mankind

7.8.1 Mankind Company Information

7.8.2 Mankind Introduction and Business Overview

7.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Mankind Long-acting and Short-acting Oral Contraceptives Product Offerings

7.8.5 Mankind Recent Development

7.9 Piramal

7.9.1 Piramal Company Information

7.9.2 Piramal Introduction and Business Overview

7.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Piramal Long-acting and Short-acting Oral Contraceptives Product Offerings

7.9.5 Piramal Recent Development

7.10 Allergan

7.10.1 Allergan Company Information

7.10.2 Allergan Introduction and Business Overview

7.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Allergan Long-acting and Short-acting Oral Contraceptives Product Offerings

7.10.5 Allergan Recent Development

8 Industry Chain Analysis

8.1 Long-acting and Short-acting Oral Contraceptives Industrial Chain

8.2 Long-acting and Short-acting Oral Contraceptives Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Long-acting and Short-acting Oral Contraceptives Sales Model

8.5.2 Sales Channel

8.5.3 Long-acting and Short-acting Oral Contraceptives Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Long-acting and Short-acting Oral Contraceptives Market Trends

Table 2. Long-acting and Short-acting Oral Contraceptives Market Drivers & Opportunity

Table 3. Long-acting and Short-acting Oral Contraceptives Market Challenges

Table 4. Long-acting and Short-acting Oral Contraceptives Market Restraints

Table 5. Global Long-acting and Short-acting Oral Contraceptives Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Company (2019-2024)

Table 7. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Long-acting and Short-acting Oral Contraceptives Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Long-acting and Short-acting Oral Contraceptives Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Long-acting and Short-acting Oral Contraceptives Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Long-acting and Short-acting Oral Contraceptives Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Long-acting and Short-acting Oral Contraceptives

Table 13. Global Long-acting and Short-acting Oral Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting and Short-acting Oral Contraceptives as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Long-acting and Short-acting Oral Contraceptives Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Long-acting and Short-acting Oral Contraceptives Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Long-acting and Short-acting Oral Contraceptives Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Long-acting and Short-acting Oral Contraceptives Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region (2019-2024) & (%)

Table 44. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Region (2025-2030) & (%)

Table 45. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (2019-2024) & (%)

Table 49. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Region (2025-2030) & (%)

Table 50. Global Long-acting and Short-acting Oral Contraceptives Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Long-acting and Short-acting Oral Contraceptives Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Volume, (2025-2030) & (K Units)

Table 57. Bayer Company Information

Table 58. Bayer Introduction and Business Overview

Table 59. Bayer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Bayer Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 61. Bayer Recent Development

Table 62. Paladin Labs Company Information

Table 63. Paladin Labs Introduction and Business Overview

Table 64. Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 66. Paladin Labs Recent Development

Table 67. Theramex (Teva) Company Information

Table 68. Theramex (Teva) Introduction and Business Overview

Table 69. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 71. Theramex (Teva) Recent Development

Table 72. Pfizer Company Information

Table 73. Pfizer Introduction and Business Overview

Table 74. Pfizer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Pfizer Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 76. Pfizer Recent Development

Table 77. Apotex Company Information

Table 78. Apotex Introduction and Business Overview

Table 79. Apotex Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Apotex Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 81. Apotex Recent Development

Table 82. HRA Pharma Company Information

Table 83. HRA Pharma Introduction and Business Overview

Table 84. HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 86. HRA Pharma Recent Development

Table 87. HLL Life Care Company Information

Table 88. HLL Life Care Introduction and Business Overview

Table 89. HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 91. HLL Life Care Recent Development

Table 92. Mankind Company Information

Table 93. Mankind Introduction and Business Overview

Table 94. Mankind Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Mankind Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 96. Mankind Recent Development

Table 97. Piramal Company Information

Table 98. Piramal Introduction and Business Overview

Table 99. Piramal Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Piramal Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 101. Piramal Recent Development

Table 102. Allergan Company Information

Table 103. Allergan Introduction and Business Overview

Table 104. Allergan Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Allergan Long-acting and Short-acting Oral Contraceptives Product Offerings

Table 106. Allergan Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Long-acting and Short-acting Oral Contraceptives Downstream Customers

Table 110. Long-acting and Short-acting Oral Contraceptives Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Long-acting and Short-acting Oral Contraceptives Product Picture

Figure 2. Global Long-acting and Short-acting Oral Contraceptives Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Long-acting and Short-acting Oral Contraceptives Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Long-acting and Short-acting Oral Contraceptives Sales Volume (2019-2030) & (K Units)

Figure 5. Global Long-acting and Short-acting Oral Contraceptives Sales Price (2019-2030) & (US$/Unit)

Figure 6. Long-acting and Short-acting Oral Contraceptives Report Years Considered

Figure 7. Global Long-acting and Short-acting Oral Contraceptives Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Long-acting and Short-acting Oral Contraceptives Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting and Short-acting Oral Contraceptives Revenue in 2023

Figure 10. Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Combined Contraceptive Pill Picture

Figure 12. Low Dose Oral Contraceptive Picture

Figure 13. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Long-acting and Short-acting Oral Contraceptives Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Long-acting and Short-acting Oral Contraceptives Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Long-acting and Short-acting Oral Contraceptives Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital Pharmacies

Figure 19. Product Picture of Private Clinics

Figure 20. Product Picture of Retail Pharmacies

Figure 21. Product Picture of E-Commerce

Figure 22. Global Long-acting and Short-acting Oral Contraceptives Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Long-acting and Short-acting Oral Contraceptives Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Long-acting and Short-acting Oral Contraceptives Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Long-acting and Short-acting Oral Contraceptives Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Long-acting and Short-acting Oral Contraceptives Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Long-acting and Short-acting Oral Contraceptives Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Long-acting and Short-acting Oral Contraceptives Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Long-acting and Short-acting Oral Contraceptives Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Long-acting and Short-acting Oral Contraceptives Sales Volume (%), (2019-2030)

Figure 39. United States Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Long-acting and Short-acting Oral Contraceptives Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Long-acting and Short-acting Oral Contraceptives Sales Value by Application (%), 2023 VS 2030

Figure 45. China Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

Figure 47. China Long-acting and Short-acting Oral Contraceptives Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Long-acting and Short-acting Oral Contraceptives Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Long-acting and Short-acting Oral Contraceptives Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Long-acting and Short-acting Oral Contraceptives Sales Value by Application (%), 2023 VS 2030

Figure 57. India Long-acting and Short-acting Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Long-acting and Short-acting Oral Contraceptives Sales Value by Type (%), 2023 VS 2030

Figure 59. India Long-acting and Short-acting Oral Contraceptives Sales Value by Application (%), 2023 VS 2030

Figure 60. Long-acting and Short-acting Oral Contraceptives Industrial Chain

Figure 61. Long-acting and Short-acting Oral Contraceptives Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-14N15115

Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Neonatal and Obstetric Monitoring Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-25J14588

Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Latex Dipping Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-11B15328

Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Fetal Fibronectin Test Diagnostic Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-35E14914

Wed Dec 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Long-acting and Short-acting Oral Contraceptives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-22I12400

Long-acting and Short-acting Oral Contraceptives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Long-acting and Short-acting Oral Contraceptives - Market Size

Long-acting and Short-acting Oral Contraceptives - Market

Report Scope

Scope of Long-acting and Short-acting Oral Contraceptives - Market Report

Chapter Outline

FAQ for this report

What is the Long-acting and Short-acting Oral Contraceptives - Market size in 2030?

Who are the main players in the Long-acting and Short-acting Oral Contraceptives - Market report?

What are the Application segmentation covered in the Long-acting and Short-acting Oral Contraceptives - Market report?

What are the Type segmentation covered in the Long-acting and Short-acting Oral Contraceptives - Market report?

FEATURED COMPANIES

RELATED REPORTS